長盈通(688143.SH):已開發出空芯光纖耦合輸出集成模塊,並已研發出空芯反諧振光纖產品
格隆匯3月25日丨長盈通(688143.SH)在投資者互動平台表示,公司持續開展微結構光纖製造及應用技術的研究,已開發出空芯光纖耦合輸出集成模塊,並已研發出空芯反諧振光纖產品。公司研製的空芯反諧振光纖主要是兩方面應用:一方面是通訊領域,公司的技術團隊在不斷優化光纖衰減,並與國內通信企業合作測試;另一方面是超快激光傳輸領域,公司持續深化空芯反諧振光纖在飛秒激光醫用碎石領域的研究,成功實現不小於30W平均功率的紅外飛秒激光傳輸,並與武漢大學人民醫院聯合完成光纖入水激光碎石驗證實驗。公司目前已經是鋭科激光和華日激光等激光器企業的供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.